Who We Are
About Human Longevity
Built by the pioneers of the human genome sequencing effort, Human Longevity is the global leader in advancing the Human Longevity Care movement, on a mission to discover and harness the technological and biological unlocks that amplify span of life, health, & high-performance.
Human Longevity, Inc. is committed to accelerating living to 100+ by revolutionizing the landscape of the current system of “sickcare” to true “healthcare”. By continually adding and analyzing our client’s health data, we are transforming treatment from a reactive practice to one that is proactive, preventative, and personalized.
J. Craig Venter, PhD
Co-Founder of Human Longevity, Inc.
“If we can predict and know at birth or even before birth our risk of cancer, of heart disease, of dementia and of different genetic diseases at the stage where you might be able to do something about them even before they occur. It’s gonna be a whole paradigm shift in medicine.”
In 2000, society oversaw Craig Venter, a brilliant geneticist, sequence the first human genome. It was the start of the genomic revolution with the vision that one day healthcare will be able to have data-driven precision-based personalized medicine that can not only intervene but also eliminate cancers and major diseases.
In 2013, Human Longevity was founded with a half a billion dollars by Craig Venter, who currently sits on our Scientific Advisory Board. What started as a research project, Human Longevity was recently commercialized by Wei-Wu He. As one of the original scientists that worked on the human genome with Craig Venter, Dr. He wanted to bring to fruition the genomic revolution and the future of proactive healthcare.
With 2,000 members in the headquarter San Diego, Human Longevity has opened two more sites in San Francisco and Beijing. Seven other locations around the world have been mapped for the next five years.